Centiva Capital, LP Abb Vie Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 5,000 shares of ABBV stock, worth $900,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,000

Previous 5,000 -0.0%

Holding current value

$900,000

Previous $857,000 15.17%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $2.12 Million - $2.58 Million	12,965 Added 108.08%	24,961 $4.93 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $1.54 Million - $1.8 Million	9,979 Added 494.74%	11,996 $2.06 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $322,356 - $367,295	2,017 New	2,017 $367,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.57 Million - $1.82 Million	11,776 New	11,776 $1.76 Million
Q2 2022 Aug 17, 2022	SELL	$137.62 - $174.96 $10.2 Million - $13 Million	-74,100 Reduced 96.2%	2,924 $448,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $9.33 Million - $11.9 Million	67,798 Added 734.86%	77,024 $11.8 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $617,930 - $766,677	4,682 Added 103.04%	9,226 $1.5 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $3.91 Million - $4.95 Million	-36,439 Reduced 88.91%	4,544 $615,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $4.36 Million - $4.95 Million	40,983 New	40,983 $4.42 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $838,523 - $934,163	-7,970 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $306,593 - $337,522	2,997 Added 60.27%	7,970 $862,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $884,665 - $1.19 Million	-10,991 Reduced 68.85%	4,973 $533,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $3.82 Million - $4.49 Million	-44,483 Reduced 73.59%	15,964 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.37 Million - $1.84 Million	18,699 Added 44.79%	60,447 $5.93 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $2.51 Million - $3.81 Million	38,934 Added 1383.58%	41,748 $3.18 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.54 Million - $3.17 Million	-35,160 Reduced 92.59%	2,814 $249,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $663,701 - $848,365	-10,102 Reduced 21.01%	37,974 $2.76 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $3.27 Million - $3.85 Million	42,422 Added 750.3%	48,076 $3.87 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $426,228 - $525,654	5,475 Added 3058.66%	5,654 $521,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $15,914 - $17,692	179 New	179 $17,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Abb Vie Inc. Transaction History